Results 181 to 190 of about 56,264 (258)

Development and validation of a risk prediction model for acute chemotherapy-induced nausea and vomiting in pediatric patients with cancers. [PDF]

Transl Pediatr
Yu L, Wu Y, Lin N, Sun C, Zhou Y, Chu X, Guan L, Bai G, Zhu J.   +8 more
europepmc   +1 more source

Rolapitant improves quality of life of patients receiving highly or moderately emetogenic chemotherapy [PDF]

, 2016

core   +1 more source

Chemotherapy-Induced Nausea and Vomiting (CINV) [PDF]

Egyptian Journal of Hematology and Bone Marrow Transplantation, 2017
openaire   +1 more source

Fosaprepitant for the prevention of multiple-day cisplatin chemotherapy-induced nausea and vomiting: a prospective randomized controlled study. [PDF]

BMC Pharmacol Toxicol
Wang L, Jin G, Wang W, Zhao J, Chen F, Li X, Jiang Y, Zhang Z, Li Q.   +8 more
europepmc   +1 more source

Efficacy of cannabinoids for the prophylaxis of chemotherapy-induced nausea and vomiting-a systematic review and meta-analysis. [PDF]

Support Care Cancer
Chow R, Basu A, Kaur J, Hui D, Im J, Prsic E, Boldt G, Lock M, Eng L, Ng TL, Zimmermann C, Scotte F.   +11 more
europepmc   +1 more source

Refractory Chemotherapy-Induced Nausea and Vomiting [PDF]

, 2020
openaire   +1 more source

Incidence and Risk Factors of Platinum-Based Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Curr Oncol
Jin K, Lin X, Xia X, Ye H, Yang D, Fan Y, Sun Q, Wang R.   +7 more
europepmc   +1 more source

Olanzapine Versus Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting: A Systematic Review and Meta-Analysis. [PDF]

Cureus
Sarma I, Buragohain S, Lahon J, Banerjee P, Kumar S, Chetia R, Baishya P, Saikia D.   +7 more
europepmc   +1 more source

Individual patient data meta-analysis of NEPA versus aprepitant-based antiemetic regimens for preventing chemotherapy-induced nausea and vomiting. [PDF]

Future Oncol
Navari RM, Tyler T, Inui N, Iihara H, Bonizzoni E, Park YH, Rugo HS, Roeland EJ.   +7 more
europepmc   +1 more source

Effective Use of Olanzapine for Chemotherapy-Induced Nausea and Vomiting in a Patient Receiving Dose-Adjusted Rituximab, Etoposide, Prednisone, Vincristine (Oncovin®), Cyclophosphamide, and Doxorubicin (R-EPOCH): A Case Report. [PDF]

Cureus
Shimada H, Ohgami M, Kurokawa Y, Tachihara S, Sugaya A.   +4 more
europepmc   +1 more source